Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
on behalf of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
Research output: Contribution to journal › Review article › peer-review
327Scopus
citations
Fingerprint
Dive into the research topics of 'Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer'. Together they form a unique fingerprint.